Levels of expression of endothelial markers specific to tumour-associated endothelial cells and their correlation with prognosis in patients with breast cancer

[1]  R. Mansel,et al.  Expression of peroxisome‐proliferator activated receptor‐gamma (PPARγ) and the PPARγ co‐activator, PGC‐1, in human breast cancer correlates with clinical outcomes , 2003 .

[2]  G. Watkins,et al.  The HGF/SF antagonist NK4 reverses fibroblast‐ and HGF‐induced prostate tumor growth and angiogenesis in vivo , 2003, International journal of cancer.

[3]  W. Jiang,et al.  Quantitative analysis of lymphangiogenic markers in human colorectal cancer. , 2003, International journal of oncology.

[4]  Ichiro Mori,et al.  Prognostic significance of vascular endothelial growth factor D in breast carcinoma with long-term follow-up. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[5]  C. Quinn,et al.  Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast , 2002, Journal of clinical pathology.

[6]  R. Mansel,et al.  Molecular detection of micro-metastasis in breast cancer. , 2002, Critical reviews in oncology/hematology.

[7]  I. Herman,et al.  Mechanisms of normal and tumor-derived angiogenesis. , 2002, American journal of physiology. Cell physiology.

[8]  J. Sloane,et al.  Vascular density and phenotype around ductal carcinoma in situ (DCIS) of the breast , 2002, British Journal of Cancer.

[9]  David A. Cheresh,et al.  Role of integrins in cell invasion and migration , 2002, Nature Reviews Cancer.

[10]  K. Alitalo,et al.  Vascular growth factors and lymphangiogenesis. , 2002, Physiological reviews.

[11]  H. Wada,et al.  Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[12]  J. Enenstein,et al.  Identification and functional assessment of endothelial P1H12. , 2001, The Journal of laboratory and clinical medicine.

[13]  K. Kinzler,et al.  Cell surface tumor endothelial markers are conserved in mice and humans. , 2001, Cancer research.

[14]  S K Libutti,et al.  Progress in antiangiogenic gene therapy of cancer , 2000, Cancer.

[15]  K. Kinzler,et al.  Genes expressed in human tumor endothelium. , 2000, Science.

[16]  D. Staunton,et al.  The leukocyte integrin alpha D beta 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1. , 1999, Journal of immunology.

[17]  S. Santoro,et al.  Ligand recognition by the I domain-containing integrins , 1998, Cellular and Molecular Life Sciences CMLS.

[18]  J. Forbes.  The incidence of breast cancer: the global burden, public health considerations. , 1997, Seminars in oncology.

[19]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[20]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[21]  R. Liddington,et al.  Crystal structure of the A domain from the a subunit of integrin CR3 (CD11 b/CD18) , 1995, Cell.

[22]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[23]  G. Viglietto,et al.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Bonaldo,et al.  The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. , 1991, Blood.

[25]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[26]  C. Carter,et al.  Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases , 1989, Cancer.

[27]  D. Gospodarowicz,et al.  Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[28]  N. Ferrara,et al.  Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. , 1989, Biochemical and biophysical research communications.

[29]  C. Redmond,et al.  Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update , 1983, Cancer.

[30]  H. Dvorak,et al.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. , 1983, Science.

[31]  M. Chir,et al.  Coarctation of the aorta associated with an aneurysm leaking into the bronchial tree, treated by aortic resection and grafting. , 1956, Proceedings of the Royal Society of Medicine.

[32]  R. Mansel,et al.  Lymphangiogenesis and breast cancer metastasis. , 2002, Histology and histopathology.

[33]  J. Folkman.  Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis. , 1995, The New England journal of medicine.